RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.
Chen L, Zhang W, Chen D, Yang Q, Sun S, Dai Z, Li Z, Liang X, Chen C, Jiao Y, Zhi L, Zhao L, Zhang J, Liu X, Zhao J, Li M, Wang Y, Qi Y.
Chen L, et al. Among authors: chen c, chen d.
Signal Transduct Target Ther. 2023 Apr 21;8(1):159. doi: 10.1038/s41392-023-01367-x.
Signal Transduct Target Ther. 2023.
PMID: 37080995
Free PMC article.